{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:52:10Z","timestamp":1792047130435,"version":"4.4.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Sexual dysfunction is one of the most frequently occurring side-effects of antipsychotic medication, impacting both quality of life and adherence to treatment. Despite this, limited evidence-based guidance on treatment options is available.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To synthesize and analyze the evidence on management of antipsychotic-related sexual dysfunction, specifically taking note of the more recently developed antipsychotics that have been incorporated in studies over the past decade.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>EMBASE, Medline, and PsychINFO databases were searched using search terms related to sexual or erectile dysfunction, treatments, and antipsychotics. 2 reviewers independently assessed papers for the inclusion criteria for randomized controlled trials (RCTs) of treatments for antipsychotic-related sexual dysfunction, including adjunctive medications and a switch of antipsychotic. Studies were excluded if participants did not have recorded sexual dysfunction at baseline.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measure<\/jats:title>\n                  <jats:p>The primary outcome measure was any change in sexual function.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>6 RCTs were identified, all of which investigated different interventions; hence, it was not possible to synthesize the data quantitatively. Results were overall limited by small sample size, brief treatment duration, and the potential for bias. 2 studies, one assessing adjunctive sildenafil and the other adjunctive aripiprazole, reported a reduction in antipsychotic-related sexual dysfunction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>Due to the lack of high-quality data, no clinical recommendations can be made.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths &amp; Limitations<\/jats:title>\n                  <jats:p>A comprehensive search strategy was used with an extensive number of relevant search terms including \u201cerectile dysfunction\u201d and newer antipsychotics such as aripiprazole. In light of evidence that prolactin is not a reliable marker for sexual dysfunction, this review focused its inclusion criteria on participants presenting with sexual dysfunction rather than with hyperprolactinemia, which should give its recommendations more validity. However, only 6 RCTs were identified, and results were overall limited by small sample size, brief treatment duration, and the potential for bias.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our findings highlight the paucity of high-quality research in this area, and conjecture that it may be difficult to recruit participants with antipsychotic-related sexual dysfunction. Future research may be necessary to unlock and address these difficulties. Furthermore, fully powered future studies should focus on the management of sexual dysfunction rather than the surrogate marker of hyperprolactinemia.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1016\/j.jsxm.2019.08.022","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T21:14:41Z","timestamp":1569964481000},"page":"1978-1987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Management of Antipsychotic-Related Sexual Dysfunction: Systematic Review"],"prefix":"10.1093","volume":"16","author":[{"given":"Kirsty","family":"Allen","sequence":"first","affiliation":[{"name":"West London NHS Trust , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Baban","sequence":"additional","affiliation":[{"name":"Central and North West London NHS Foundation Trust , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasna","family":"Munjiza","sequence":"additional","affiliation":[{"name":"Central and North West London NHS Foundation Trust , London , UK"},{"name":"Centre for Psychiatry, Faculty of Medicine, Imperial College London , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Pappa","sequence":"additional","affiliation":[{"name":"West London NHS Trust , London , UK"},{"name":"Centre for Psychiatry, Faculty of Medicine, Imperial College London , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"key":"2023012309482556100_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-2007-981480","article-title":"Sexual dysfunction in psychiatric inpatients: the role of antipsychotic medication","volume":"40","author":"Westheide","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"2023012309482556100_bib2","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.euroneuro.2009.03.003","article-title":"Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study","volume":"19","author":"Novick","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"2023012309482556100_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12991-017-0166-y","article-title":"Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics","volume":"16","author":"Kirino","year":"2017","journal-title":"Ann Gen Psychiatry"},{"key":"2023012309482556100_bib4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/0092623X.2011.606884","article-title":"Subjective quality of life and sexual dysfunction in outpatients with schizophrenia or schizoaffective disorder","volume":"39","author":"Bushong","year":"2013","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2023012309482556100_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/00926230390195524","article-title":"A\u00a0survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance","volume":"29","author":"Rosenberg","year":"2003","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2023012309482556100_bib6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/schbul\/sbv001","article-title":"The facts about sexual (dys)function in schizophrenia: an overview of clinically relevant findings","volume":"41","author":"de Boer","year":"2015","journal-title":"Schizophr Bull"},{"key":"2023012309482556100_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/713847170","article-title":"Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study","volume":"29","author":"Bobes","year":"2003","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2023012309482556100_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/YIC.0b013e328341e434","article-title":"A\u00a0meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics","volume":"26","author":"Serretti","year":"2011","journal-title":"Int Clin Psychopharmacol"},{"key":"2023012309482556100_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/01.jcp.0000186872.04984.56","article-title":"A\u00a06-month prospective observational study on the effects of quetiapine on sexual functioning","volume":"25","author":"Montejo Gonzalez","year":"2005","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"2023012309482556100_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/JCP.0b013e31818501a1","article-title":"Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study","volume":"28","author":"Montejo","year":"2008","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"2023012309482556100_bib11","first-page":"13","article-title":"Observational, open-label, prospective multicenter study of sexual function in patients starting treatment with aripiprazole","volume":"38","author":"Montejo","year":"2010","journal-title":"Actas Esp Psiquiatr"},{"key":"2023012309482556100_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/JCP.0b013e3182199bcc","article-title":"Sexual dysfunction in first-episode schizophrenia patients. Results from European First Episode Schizophrenia Trial","volume":"31","author":"Malik","year":"2011","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"2023012309482556100_bib13","first-page":"56","article-title":"A\u00a0randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning","volume":"24","author":"Knegtering","year":"2004","journal-title":"J\u00a0Clin Pharmacol"},{"key":"2023012309482556100_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.psyneuen.2005.08.010","article-title":"A\u00a0randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia","volume":"31","author":"Kelly","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"2023012309482556100_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.psychres.2007.02.014","article-title":"Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial","volume":"159","author":"Byerly","year":"2008","journal-title":"Psychiatry Res"},{"key":"2023012309482556100_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-244X-8-95","article-title":"The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913)","volume":"8","author":"Hanssens","year":"2008","journal-title":"BMC Psychiatry"},{"key":"2023012309482556100_bib17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/JCP.0b013e318222bb29","article-title":"A\u00a0randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS Study)","volume":"31","author":"de Boer","year":"2011","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"2023012309482556100_bib18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/WNF.0000000000000175","article-title":"Comparing the effectiveness and safety of the addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia: a multicenter, open-label, prospective study","volume":"39","author":"Yoon","year":"2016","journal-title":"Clin Neuropharmacol"},{"key":"2023012309482556100_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/YIC.0000000000000168","article-title":"Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY","volume":"32","author":"Potkin","year":"2017","journal-title":"Int Clin Psychopharmacol"},{"key":"2023012309482556100_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00002826-200307000-00008","article-title":"Selegiline in the treatment of sexual dysfunction in schizophrenic patients maintained on neuroleptics: a pilot study","volume":"26","author":"Kodesh","year":"2003","journal-title":"Clin Neuropharmacol"},{"key":"2023012309482556100_bib21","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1176\/appi.ajp.2007.06071075","article-title":"Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial","volume":"164","author":"Shim","year":"2007","journal-title":"Am J Psychiatry"},{"key":"2023012309482556100_bib22","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.4088\/JCP.09m05154yel","article-title":"A\u00a0multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy","volume":"70","author":"Kane","year":"2009","journal-title":"J\u00a0Clin Psychiatry"},{"key":"2023012309482556100_bib23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1192\/bjpo.bp.115.001248","article-title":"Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial","volume":"1","author":"Raghuthaman","year":"2015","journal-title":"BJPsych Open"},{"key":"2023012309482556100_bib24","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1176\/appi.ajp.163.3.494","article-title":"Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a\u00a0randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial","volume":"163","author":"Gopalakrishnan","year":"2006","journal-title":"Am J Psychiatry"},{"key":"2023012309482556100_bib25","first-page":"1136","article-title":"Adjunctive treatment with lodenafil carbonate for erectile dysfunction in outpatients with schizophrenia and spectrum: a randomized, double-blind, crossover, placebo-controlled trial","volume":"10","author":"Nunes","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"2023012309482556100_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/JCP.0000000000000113","article-title":"Efficacy of tadalafil on erectile dysfunction in male patients using antipsychotics. a double-blind, placebo-controlled, crossover pilot study","volume":"34","author":"de Boer","year":"2014","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"2023012309482556100_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12888-016-1103-3","article-title":"Prolactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia","volume":"16","author":"Bo","year":"2016","journal-title":"BMC Psychiatry"},{"key":"2023012309482556100_bib28","first-page":"CD003546","article-title":"Management of sexual dysfunction due to antipsychotic drug therapy","volume":"11","author":"Schmidt","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2023012309482556100_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3371\/CSRP.3.4.3","article-title":"A\u00a0pilot study to determine a prolactin threshold that identifies improved sexual functioning when switching from a prolactin-elevating to a prolactin-neutral antipsychotic","volume":"3","author":"Byerly","year":"2010","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"2023012309482556100_bib30","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and met-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2023012309482556100_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/009262300278623","article-title":"The Arizona Sexual Experience Scale (ASEX): reliability and validity","volume":"26","author":"McGahuey","year":"2000","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2023012309482556100_bib32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ijir.3900857","article-title":"The International Index of Erectile Function (IIEF): a state-of-the-science review","volume":"14","author":"Rosen","year":"2002","journal-title":"Int J Impot Res"},{"key":"2023012309482556100_bib33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/JCP.0000000000000898","article-title":"Adjunct aripiprazole reduces prolactin and prolactin-related adverse effects in premenopausal women with psychosis","volume":"38","author":"Kelly","year":"2018","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"2023012309482556100_bib34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1471-244X-13-214","article-title":"Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)","volume":"13","author":"Kelly","year":"2013","journal-title":"BMC Psychiatry"},{"key":"2023012309482556100_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.psyneuen.2008.02.008","article-title":"Are sexual\u00a0side effects of prolactin-raising antipsychotics reducible\u00a0to serum prolactin?","volume":"33","author":"Knegtering","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"2023012309482556100_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.ijir.3900906","article-title":"Sildenafil use in patients with olanzapine-induced erectile dysfunction","volume":"14","author":"Atamaca","year":"2002","journal-title":"Int J Impot Res"},{"key":"2023012309482556100_bib37","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4088\/JCP.v69n0206","article-title":"Vardenafil in the treatment of erectile dysfunction in outpatients with chronic schizophrenia: a flexible-dose, open-label study","volume":"69","author":"Mitsonis","year":"2008","journal-title":"J\u00a0Clin Psychiatry"},{"key":"2023012309482556100_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4088\/JCP.v65n0117","article-title":"An open-label trial of sildenafil addition in risperidone-treated male schizophrenia patients with erectile dysfunction","volume":"65","author":"Aviv","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"key":"2023012309482556100_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00004714-198704000-00008","article-title":"Amantadine in the treatment of neuroendocrine side effects of neuroleptics","volume":"7","author":"Correa","year":"1987","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"2023012309482556100_bib40","first-page":"355","article-title":"Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients","volume":"21","author":"Valevski","year":"1998","journal-title":"Clin Neuropharmacol"},{"key":"2023012309482556100_bib41","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/157488612802715753","article-title":"Safety of cabergoline in the management of pituitary prolactin-induced symptoms with patients treated with atypical neuroleptics","volume":"7","author":"Coronas","year":"2012","journal-title":"Curr Drug Saf"},{"key":"2023012309482556100_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/0092623X.2011.606883","article-title":"Strategies for the treatment of antipsychotic-induced sexual dysfunction and\/or hyperprolactinemia among patients of the schizophrenia spectrum: a review","volume":"38","author":"Nunes","year":"2012","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2023012309482556100_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/wps.20509","article-title":"The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management","volume":"17","author":"Montejo","year":"2018","journal-title":"World Psychiatry"},{"key":"2023012309482556100_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/08039488.2016.1233996","article-title":"Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics","volume":"71","author":"Terevnikov","year":"2017","journal-title":"Nord J Psychiatry"},{"key":"2023012309482556100_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejpsy.2017.08.005","article-title":"The effect of bupropion on sexual function in patients with schizophrenia: a randomized clinical trial","volume":"32","author":"Rezaei","year":"2018","journal-title":"Eur J Psychiatry"},{"key":"2023012309482556100_bib46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/JCP.0b013e318172473c","article-title":"A\u00a0randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia","volume":"28","author":"Yuan","year":"2008","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"2023012309482556100_bib47","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1176\/appi.ajp.2012.11091432","article-title":"Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study","volume":"169","author":"Wu","year":"2012","journal-title":"Am J Psychiatry"},{"key":"2023012309482556100_bib48","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004714-199710000-00010","article-title":"Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders","volume":"17","author":"Tran","year":"1997","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"2023012309482556100_bib49","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.psyneuen.2005.12.006","article-title":"Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine","volume":"31","author":"Kinon","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"2023012309482556100_bib50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/00926230600666378","article-title":"A\u00a0randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning","volume":"32","author":"Knegtering","year":"2006","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2023012309482556100_bib51","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/2045125315606027","article-title":"A\u00a06-week, double-blind, placebo- and haloperidol-controlled, phase II study of lurasidone in patients with acute schizophrenia","volume":"5","author":"Potkin","year":"2015","journal-title":"Ther Adv Psychopharmacol"},{"key":"2023012309482556100_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijgo.2015.08.015","article-title":"Systematic review and meta-analysis of phosphodiesterase type 5 inhibitors for the treatment of female sexual dysfunction","volume":"133","author":"Gao","year":"2016","journal-title":"Int J Gynaecol Obstet"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609519313918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609519313918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/16\/12\/1978\/48589252\/jsm_16_12_1978.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/16\/12\/1978\/48589252\/jsm_16_12_1978.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T10:26:22Z","timestamp":1674469582000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/16\/12\/1978\/6980651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":52,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,10,1]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2019.08.022","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,10,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Antipsychotic-Related Sexual Dysfunction: Systematic Review","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2019.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}